Release Date: 02/05/22 07:50 Summary: Quarterly Cashflow Report Price Sensitive: Yes Download Document 278.8KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%